Literature DB >> 34893682

PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer's disease.

Xiao-Juan Wang1, Lin Qi1, Ya-Fang Cheng1, Xue-Fei Ji1, Tian-Yan Chi1, Peng Liu2, Li-Bo Zou3.   

Abstract

PTEN-induced putative kinase 1 (PINK1)/parkin pathway mediates mitophagy, which is a specialized form of autophagy. Evidence shows that PINK1 can exert protective effects against stress-induced neuronal cell death. In the present study we investigated the effects of PINK1 overexpression on tau hyperphosphorylation, mitochondrial dysfunction and oxidative stress in a specific rat model of tau hyperphosphorylation. We showed that intracerebroventricular (ICV) microinjection of forskolin (FSK, 80 μmol) induced tau hyperphosphorylation in the rat brain and resulted in significant spatial working memory impairments in Y-maze test, accompanied by synaptic dysfunction (reduced expression of synaptic proteins synaptophysin and postsynaptic density protein 95), and neuronal loss in the hippocampus. Adeno-associated virus (AAV)-mediated overexpression of PINK1 prevented ICV-FSK-induced cognition defect and pathological alterations in the hippocampus, whereas PINK1-knockout significantly exacerbated ICV-FSK-induced deteriorated effects. Furthermore, we revealed that AAV-PINK1-mediated overexpression of PINK1 alleviated ICV-FSK-induced tau hyperphosphorylation by restoring the activity of PI3K/Akt/GSK3β signaling. PINK1 overexpression reversed the abnormal changes in mitochondrial dynamics, defective mitophagy, and decreased ATP levels in the hippocampus. Moreover, PINK1 overexpression activated Nrf2 signaling, thereby increasing the expression of antioxidant proteins and reducing oxidative damage. These results suggest that PINK1 deficiency exacerbates FSK-induced tau pathology, synaptic damage, mitochondrial dysfunction, and antioxidant system defects, which were reversed by PINK1 overexpression. Our data support a critical role of PINK1-mediated mitophagy in controlling mitochondrial quality, tau hyperphosphorylation, and oxidative stress in a rat model of Alzheimer's disease.
© 2021. The Author(s), under exclusive licence to CPS and SIMM.

Entities:  

Keywords:  Alzheimer’s disease; Forskolin; Nrf2 signaling; PI3K/Akt/GSK3β signaling; PINK1; Tau hyperphosphorylation; mitophagy; oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 34893682      PMCID: PMC9343460          DOI: 10.1038/s41401-021-00810-5

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   7.169


  58 in total

1.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

2.  Phosphatase 2A Inhibition Affects Endoplasmic Reticulum and Mitochondria Homeostasis Via Cytoskeletal Alterations in Brain Endothelial Cells.

Authors:  Ana I Plácido; Cláudia M F Pereira; Sónia C Correira; Cristina Carvalho; Catarina R Oliveira; Paula I Moreira
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

3.  Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5.

Authors:  Shiori Sekine; Yusuke Kanamaru; Masato Koike; Ayako Nishihara; Masahiro Okada; Hideyuki Kinoshita; Miki Kamiyama; Junichi Maruyama; Yasuo Uchiyama; Naotada Ishihara; Kohsuke Takeda; Hidenori Ichijo
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

4.  PINK1 overexpression protects against cerebral ischemia through Parkin regulation.

Authors:  Youliang Wen; Yueming Gu; Xiaodong Tang; Ziwei Hu
Journal:  Environ Toxicol       Date:  2019-10-26       Impact factor: 4.119

5.  Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.

Authors:  Evandro F Fang; Yujun Hou; Konstantinos Palikaras; Bryan A Adriaanse; Jesse S Kerr; Beimeng Yang; Sofie Lautrup; Md Mahdi Hasan-Olive; Domenica Caponio; Xiuli Dan; Paula Rocktäschel; Deborah L Croteau; Mansour Akbari; Nigel H Greig; Tormod Fladby; Hilde Nilsen; M Zameel Cader; Mark P Mattson; Nektarios Tavernarakis; Vilhelm A Bohr
Journal:  Nat Neurosci       Date:  2019-02-11       Impact factor: 24.884

Review 6.  Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.

Authors:  P Hemachandra Reddy; Darryll Ma Oliver
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

7.  Disease-associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria.

Authors:  Nadia Cummins; Andrea Tweedie; Steven Zuryn; Jesus Bertran-Gonzalez; Jürgen Götz
Journal:  EMBO J       Date:  2018-12-11       Impact factor: 11.598

8.  Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin.

Authors:  Yu Hu; Xia-Chun Li; Zhi-hao Wang; Yu Luo; Xiangnan Zhang; Xiu-Ping Liu; Qiong Feng; Qun Wang; Zhenyu Yue; Zhong Chen; Keqiang Ye; Jian-Zhi Wang; Gong-Ping Liu
Journal:  Oncotarget       Date:  2016-04-05

9.  Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology.

Authors:  Xu Hou; Jens O Watzlawik; Casey Cook; Chia-Chen Liu; Silvia S Kang; Wen-Lang Lin; Michael DeTure; Michael G Heckman; Nancy N Diehl; Fadi S Hanna Al-Shaikh; Ronald L Walton; Owen A Ross; Heather L Melrose; Nilüfer Ertekin-Taner; Guojun Bu; Leonard Petrucelli; John D Fryer; Melissa E Murray; Dennis W Dickson; Fabienne C Fiesel; Wolfdieter Springer
Journal:  Alzheimers Dement       Date:  2020-10-08       Impact factor: 16.655

10.  Mitophagy in degenerative joint diseases.

Authors:  Kai Sun; Xingzhi Jing; Jiachao Guo; Xudong Yao; Fengjing Guo
Journal:  Autophagy       Date:  2020-09-24       Impact factor: 16.016

View more
  1 in total

Review 1.  Redox signaling at the crossroads of human health and disease.

Authors:  Jing Zuo; Zhe Zhang; Maochao Luo; Li Zhou; Edouard C Nice; Wei Zhang; Chuang Wang; Canhua Huang
Journal:  MedComm (2020)       Date:  2022-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.